Authors:
Joki, T
Machluf, M
Atala, A
Zhu, JH
Seyfried, NT
Dunn, IF
Abe, T
Carroll, RS
Black, PM
Citation: T. Joki et al., Continuous release of endostatin from microencapsulated engineered cells for tumor therapy, NAT BIOTECH, 19(1), 2001, pp. 35-39
Authors:
Tsitsikov, EN
Laouini, D
Dunn, IF
Sannikova, TY
Davidson, L
Alt, FW
Geha, RS
Citation: En. Tsitsikov et al., TRAF1 is a negative regulator of TNF signaling: Enhanced TNF signaling in TRAF1-deficient mice, IMMUNITY, 15(4), 2001, pp. 647-657
Authors:
Joki, T
Carroll, RS
Dunn, IF
Zhang, JP
Abe, T
Black, PM
Citation: T. Joki et al., Assessment of alterations in gene expression in recurrent malignant gliomaafter radiotherapy using complementary deoxyribonucleic acid microarrays, NEUROSURGER, 48(1), 2001, pp. 195-201
Authors:
Tsai, EY
Falvo, JV
Tsytsykova, AV
Barczak, AK
Reimold, AM
Glimcher, LH
Fenton, MJ
Gordon, DC
Dunn, IF
Goldfeld, AE
Citation: Ey. Tsai et al., A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factoralpha promoter in vivo, MOL CELL B, 20(16), 2000, pp. 6084-6094
Authors:
Dunn, IF
Sannikova, TY
Geha, RS
Tsitsikov, EN
Citation: If. Dunn et al., Identification and characterization of two CD40-inducible enhancers in themouse TRAF1 gene locus, MOL IMMUNOL, 37(16), 2000, pp. 961-973
Citation: If. Dunn et Pm. Black, Matrix metalloproteinases and their inhibitors in human pituitary tumors -Comment, NEUROSURGER, 45(6), 1999, pp. 1440-1441
Authors:
Solomon, KR
Kurt-Jones, EA
Saladino, RA
Stack, AM
Dunn, IF
Ferretti, M
Golenbock, D
Fleisher, GR
Finberg, RW
Citation: Kr. Solomon et al., Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide, J CLIN INV, 102(11), 1998, pp. 2019-2027